NDC properties for "tetracycline HCl 3 % Topical Ointment" (RxCUI 1542813)
About this data
The tables show NDC propoerties for tetracycline HCl 3 % Topical Ointment with the RxCUI 1542813
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for tetracycline HCl 3 % Topical Ointment (RxCUI 1542813)
| MMSL_CODE | BD5415 |
|---|---|
| MMSL_CODE | CD5415 |
| RxCUI | 1542813 |
| SPL_SET_ID | 01c726c5-2538-4ec2-bca3-4fb8c461233d |
| SPL_SET_ID | 1c6c18db-5e42-4942-a611-00d49651a91f |
| SPL_SET_ID | 2601650a-1870-4fe5-9931-842fb2381c94 |
| SPL_SET_ID | 2c2b4ce1-2a54-4ff4-a660-14629a3df69f |
| SPL_SET_ID | 3a5e4a8e-20bb-4bf8-8a2e-8dfd7f2afb49 |
| SPL_SET_ID | 4ac5177d-bb67-45e6-adcf-44f0821746bd |
| SPL_SET_ID | 647918a1-f49f-ef01-e053-2a91aa0a11fb |
| SPL_SET_ID | 9215ec6b-69df-4b7d-b426-af50955d2c7c |
| SPL_SET_ID | 9b3c7b34-abd9-417b-a2e9-b7e857339ff5 |
| SPL_SET_ID | a6630858-7038-425f-8a75-bb25f36a0dbe |
| SPL_SET_ID | ab95442b-9a0d-ecd5-e053-2a95a90a8007 |
| SPL_SET_ID | b1c971ef-848c-6276-e053-2a95a90ac5c1 |
| SPL_SET_ID | d277e34c-bf05-42a4-9bbf-860cba62d060 |
| SPL_SET_ID | e1f206fb-ffa0-01a8-e053-2995a90ae448 |
| VUID | 4001922 |
| Prescribable Synonym | tetracycline HCl 3 % Topical Ointment |
| RXNAV_STR | tetracycline hydrochloride 0.03 MG/MG Topical Ointment |
| RxNorm Name | tetracycline hydrochloride 0.03 MG/MG Topical Ointment |
| RxNorm Synonym | tetracycline HCl 3 % Topical Ointment |
| Related queries | Interactions (for RxCUI 1542813) |
NDC Properties
NDC Item 43074010301
| NDC 9 | 43074-103 |
|---|---|
| NDC 10 | 43074-103-01 |
| NDC Item | 43074010301 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 30125 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2010-08-24 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-103 |
NDC Item 43074010801
| NDC 9 | 43074-108 |
|---|---|
| NDC 10 | 43074-108-01 |
| NDC Item | 43074010801 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 30283 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2010-08-24 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-108 |
NDC Item 43074011501
| NDC 9 | 43074-115 |
|---|---|
| NDC 10 | 43074-115-01 |
| NDC Item | 43074011501 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 38806 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2011-02-15 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-115 |
NDC Item 43074011601
| NDC 9 | 43074-116 |
|---|---|
| NDC 10 | 43074-116-01 |
| NDC Item | 43074011601 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 38788 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2011-02-15 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-116 |
NDC Item 69006001100
| NDC 9 | 69006-011 |
|---|---|
| NDC 10 | 69006-011-00 |
| NDC Item | 69006001100 |
| Packaging | 1 BOTTLE in 1 BOX (69006-011-00) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 750209 |
| Labeler | Viaderma II, Inc |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2020-05-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 69006-011 |
NDC Item 71262000200
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-00 |
| NDC Item | 71262000200 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-00) / 5 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000201
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-01 |
| NDC Item | 71262000201 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-01) / 60 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000202
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-02 |
| NDC Item | 71262000202 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-02) / 100 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000215
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-15 |
| NDC Item | 71262000215 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-15) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000901
| NDC 9 | 71262-009 |
|---|---|
| NDC 10 | 71262-009-01 |
| NDC Item | 71262000901 |
| Packaging | 1 BOTTLE in 1 CARTON (71262-009-01) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 801037 |
| Labeler | VIADERMA DISTRIBUTION INC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2024-05-01 |
| Marketing status | active |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-009 |
NDC Item 72053000000
| NDC 9 | 72053-000 |
|---|---|
| NDC 10 | 72053-000-00 |
| NDC Item | 72053000000 |
| Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-000-00) / 3 g in 1 BOTTLE, DROPPER |
| FDA SPL set id | 750517 |
| Labeler | Patient Focused Tele-Health, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2018-04-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 72053-000 |
NDC Item 72053000201
| NDC 9 | 72053-002 |
|---|---|
| NDC 10 | 72053-002-01 |
| NDC Item | 72053000201 |
| Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-002-01) / 3 g in 1 BOTTLE, DROPPER |
| FDA SPL set id | 750595 |
| Labeler | Patient Focused Tele-Health, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2020-09-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 72053-002 |
NDC Item 79790000000
| NDC 9 | 79790-000 |
|---|---|
| NDC 10 | 79790-000-00 |
| NDC Item | 79790000000 |
| Packaging | 1 BOTTLE in 1 BOX (79790-000-00) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 750404 |
| Labeler | WOUNDS PROS, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2020-07-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 79790-000 |
NDC Item 82776000015
| NDC 9 | 82776-000 |
|---|---|
| NDC 10 | 82776-000-15 |
| NDC Item | 82776000015 |
| Packaging | 1 BOTTLE in 1 BOX (82776-000-15) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 753734 |
| Labeler | THE WOUND DOCS, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2022-06-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 82776-000 |
NDC Item 43074010301
| NDC 9 | 43074-103 |
|---|---|
| NDC 10 | 43074-103-01 |
| NDC Item | 43074010301 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 30125 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2010-08-24 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-103 |
NDC Item 43074010801
| NDC 9 | 43074-108 |
|---|---|
| NDC 10 | 43074-108-01 |
| NDC Item | 43074010801 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 30283 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2010-08-24 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-108 |
NDC Item 43074011501
| NDC 9 | 43074-115 |
|---|---|
| NDC 10 | 43074-115-01 |
| NDC Item | 43074011501 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 38806 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2011-02-15 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-115 |
NDC Item 43074011601
| NDC 9 | 43074-116 |
|---|---|
| NDC 10 | 43074-116-01 |
| NDC Item | 43074011601 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 38788 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2011-02-15 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-116 |
NDC Item 69006001100
| NDC 9 | 69006-011 |
|---|---|
| NDC 10 | 69006-011-00 |
| NDC Item | 69006001100 |
| Packaging | 1 BOTTLE in 1 BOX (69006-011-00) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 750209 |
| Labeler | Viaderma II, Inc |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2020-05-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 69006-011 |
NDC Item 71262000200
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-00 |
| NDC Item | 71262000200 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-00) / 5 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000201
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-01 |
| NDC Item | 71262000201 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-01) / 60 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000202
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-02 |
| NDC Item | 71262000202 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-02) / 100 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000215
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-15 |
| NDC Item | 71262000215 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-15) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000901
| NDC 9 | 71262-009 |
|---|---|
| NDC 10 | 71262-009-01 |
| NDC Item | 71262000901 |
| Packaging | 1 BOTTLE in 1 CARTON (71262-009-01) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 801037 |
| Labeler | VIADERMA DISTRIBUTION INC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2024-05-01 |
| Marketing status | active |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-009 |
NDC Item 72053000000
| NDC 9 | 72053-000 |
|---|---|
| NDC 10 | 72053-000-00 |
| NDC Item | 72053000000 |
| Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-000-00) / 3 g in 1 BOTTLE, DROPPER |
| FDA SPL set id | 750517 |
| Labeler | Patient Focused Tele-Health, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2018-04-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 72053-000 |
NDC Item 72053000201
| NDC 9 | 72053-002 |
|---|---|
| NDC 10 | 72053-002-01 |
| NDC Item | 72053000201 |
| Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-002-01) / 3 g in 1 BOTTLE, DROPPER |
| FDA SPL set id | 750595 |
| Labeler | Patient Focused Tele-Health, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2020-09-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 72053-002 |
NDC Item 79790000000
| NDC 9 | 79790-000 |
|---|---|
| NDC 10 | 79790-000-00 |
| NDC Item | 79790000000 |
| Packaging | 1 BOTTLE in 1 BOX (79790-000-00) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 750404 |
| Labeler | WOUNDS PROS, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2020-07-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 79790-000 |
NDC Item 82776000015
| NDC 9 | 82776-000 |
|---|---|
| NDC 10 | 82776-000-15 |
| NDC Item | 82776000015 |
| Packaging | 1 BOTTLE in 1 BOX (82776-000-15) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 753734 |
| Labeler | THE WOUND DOCS, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2022-06-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 82776-000 |
NDC Item 43074010301
| NDC 9 | 43074-103 |
|---|---|
| NDC 10 | 43074-103-01 |
| NDC Item | 43074010301 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 30125 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2010-08-24 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-103 |
NDC Item 43074010801
| NDC 9 | 43074-108 |
|---|---|
| NDC 10 | 43074-108-01 |
| NDC Item | 43074010801 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 30283 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2010-08-24 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-108 |
NDC Item 43074011501
| NDC 9 | 43074-115 |
|---|---|
| NDC 10 | 43074-115-01 |
| NDC Item | 43074011501 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 38806 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2011-02-15 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-115 |
NDC Item 43074011601
| NDC 9 | 43074-116 |
|---|---|
| NDC 10 | 43074-116-01 |
| NDC Item | 43074011601 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 38788 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2011-02-15 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-116 |
NDC Item 69006001100
| NDC 9 | 69006-011 |
|---|---|
| NDC 10 | 69006-011-00 |
| NDC Item | 69006001100 |
| Packaging | 1 BOTTLE in 1 BOX (69006-011-00) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 750209 |
| Labeler | Viaderma II, Inc |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2020-05-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 69006-011 |
NDC Item 71262000200
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-00 |
| NDC Item | 71262000200 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-00) / 5 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000201
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-01 |
| NDC Item | 71262000201 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-01) / 60 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000202
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-02 |
| NDC Item | 71262000202 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-02) / 100 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000215
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-15 |
| NDC Item | 71262000215 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-15) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000901
| NDC 9 | 71262-009 |
|---|---|
| NDC 10 | 71262-009-01 |
| NDC Item | 71262000901 |
| Packaging | 1 BOTTLE in 1 CARTON (71262-009-01) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 801037 |
| Labeler | VIADERMA DISTRIBUTION INC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2024-05-01 |
| Marketing status | active |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-009 |
NDC Item 72053000000
| NDC 9 | 72053-000 |
|---|---|
| NDC 10 | 72053-000-00 |
| NDC Item | 72053000000 |
| Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-000-00) / 3 g in 1 BOTTLE, DROPPER |
| FDA SPL set id | 750517 |
| Labeler | Patient Focused Tele-Health, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2018-04-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 72053-000 |
NDC Item 72053000201
| NDC 9 | 72053-002 |
|---|---|
| NDC 10 | 72053-002-01 |
| NDC Item | 72053000201 |
| Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-002-01) / 3 g in 1 BOTTLE, DROPPER |
| FDA SPL set id | 750595 |
| Labeler | Patient Focused Tele-Health, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2020-09-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 72053-002 |
NDC Item 79790000000
| NDC 9 | 79790-000 |
|---|---|
| NDC 10 | 79790-000-00 |
| NDC Item | 79790000000 |
| Packaging | 1 BOTTLE in 1 BOX (79790-000-00) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 750404 |
| Labeler | WOUNDS PROS, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2020-07-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 79790-000 |
NDC Item 82776000015
| NDC 9 | 82776-000 |
|---|---|
| NDC 10 | 82776-000-15 |
| NDC Item | 82776000015 |
| Packaging | 1 BOTTLE in 1 BOX (82776-000-15) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 753734 |
| Labeler | THE WOUND DOCS, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2022-06-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 82776-000 |
NDC Item 43074010301
| NDC 9 | 43074-103 |
|---|---|
| NDC 10 | 43074-103-01 |
| NDC Item | 43074010301 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 30125 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2010-08-24 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-103 |
NDC Item 43074010801
| NDC 9 | 43074-108 |
|---|---|
| NDC 10 | 43074-108-01 |
| NDC Item | 43074010801 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 30283 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2010-08-24 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-108 |
NDC Item 43074011501
| NDC 9 | 43074-115 |
|---|---|
| NDC 10 | 43074-115-01 |
| NDC Item | 43074011501 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 38806 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2011-02-15 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-115 |
NDC Item 43074011601
| NDC 9 | 43074-116 |
|---|---|
| NDC 10 | 43074-116-01 |
| NDC Item | 43074011601 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 38788 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2011-02-15 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-116 |
NDC Item 69006001100
| NDC 9 | 69006-011 |
|---|---|
| NDC 10 | 69006-011-00 |
| NDC Item | 69006001100 |
| Packaging | 1 BOTTLE in 1 BOX (69006-011-00) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 750209 |
| Labeler | Viaderma II, Inc |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2020-05-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 69006-011 |
NDC Item 71262000200
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-00 |
| NDC Item | 71262000200 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-00) / 5 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000201
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-01 |
| NDC Item | 71262000201 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-01) / 60 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000202
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-02 |
| NDC Item | 71262000202 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-02) / 100 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000215
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-15 |
| NDC Item | 71262000215 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-15) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000901
| NDC 9 | 71262-009 |
|---|---|
| NDC 10 | 71262-009-01 |
| NDC Item | 71262000901 |
| Packaging | 1 BOTTLE in 1 CARTON (71262-009-01) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 801037 |
| Labeler | VIADERMA DISTRIBUTION INC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2024-05-01 |
| Marketing status | active |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-009 |
NDC Item 72053000000
| NDC 9 | 72053-000 |
|---|---|
| NDC 10 | 72053-000-00 |
| NDC Item | 72053000000 |
| Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-000-00) / 3 g in 1 BOTTLE, DROPPER |
| FDA SPL set id | 750517 |
| Labeler | Patient Focused Tele-Health, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2018-04-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 72053-000 |
NDC Item 72053000201
| NDC 9 | 72053-002 |
|---|---|
| NDC 10 | 72053-002-01 |
| NDC Item | 72053000201 |
| Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-002-01) / 3 g in 1 BOTTLE, DROPPER |
| FDA SPL set id | 750595 |
| Labeler | Patient Focused Tele-Health, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2020-09-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 72053-002 |
NDC Item 79790000000
| NDC 9 | 79790-000 |
|---|---|
| NDC 10 | 79790-000-00 |
| NDC Item | 79790000000 |
| Packaging | 1 BOTTLE in 1 BOX (79790-000-00) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 750404 |
| Labeler | WOUNDS PROS, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2020-07-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 79790-000 |
NDC Item 82776000015
| NDC 9 | 82776-000 |
|---|---|
| NDC 10 | 82776-000-15 |
| NDC Item | 82776000015 |
| Packaging | 1 BOTTLE in 1 BOX (82776-000-15) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 753734 |
| Labeler | THE WOUND DOCS, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2022-06-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 82776-000 |
NDC Item 43074010301
| NDC 9 | 43074-103 |
|---|---|
| NDC 10 | 43074-103-01 |
| NDC Item | 43074010301 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 30125 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2010-08-24 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-103 |
NDC Item 43074010801
| NDC 9 | 43074-108 |
|---|---|
| NDC 10 | 43074-108-01 |
| NDC Item | 43074010801 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 30283 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2010-08-24 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-108 |
NDC Item 43074011501
| NDC 9 | 43074-115 |
|---|---|
| NDC 10 | 43074-115-01 |
| NDC Item | 43074011501 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 38806 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2011-02-15 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-115 |
NDC Item 43074011601
| NDC 9 | 43074-116 |
|---|---|
| NDC 10 | 43074-116-01 |
| NDC Item | 43074011601 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 38788 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2011-02-15 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-116 |
NDC Item 69006001100
| NDC 9 | 69006-011 |
|---|---|
| NDC 10 | 69006-011-00 |
| NDC Item | 69006001100 |
| Packaging | 1 BOTTLE in 1 BOX (69006-011-00) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 750209 |
| Labeler | Viaderma II, Inc |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2020-05-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 69006-011 |
NDC Item 71262000200
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-00 |
| NDC Item | 71262000200 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-00) / 5 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000201
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-01 |
| NDC Item | 71262000201 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-01) / 60 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000202
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-02 |
| NDC Item | 71262000202 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-02) / 100 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000215
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-15 |
| NDC Item | 71262000215 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-15) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000901
| NDC 9 | 71262-009 |
|---|---|
| NDC 10 | 71262-009-01 |
| NDC Item | 71262000901 |
| Packaging | 1 BOTTLE in 1 CARTON (71262-009-01) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 801037 |
| Labeler | VIADERMA DISTRIBUTION INC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2024-05-01 |
| Marketing status | active |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-009 |
NDC Item 72053000000
| NDC 9 | 72053-000 |
|---|---|
| NDC 10 | 72053-000-00 |
| NDC Item | 72053000000 |
| Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-000-00) / 3 g in 1 BOTTLE, DROPPER |
| FDA SPL set id | 750517 |
| Labeler | Patient Focused Tele-Health, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2018-04-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 72053-000 |
NDC Item 72053000201
| NDC 9 | 72053-002 |
|---|---|
| NDC 10 | 72053-002-01 |
| NDC Item | 72053000201 |
| Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-002-01) / 3 g in 1 BOTTLE, DROPPER |
| FDA SPL set id | 750595 |
| Labeler | Patient Focused Tele-Health, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2020-09-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 72053-002 |
NDC Item 79790000000
| NDC 9 | 79790-000 |
|---|---|
| NDC 10 | 79790-000-00 |
| NDC Item | 79790000000 |
| Packaging | 1 BOTTLE in 1 BOX (79790-000-00) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 750404 |
| Labeler | WOUNDS PROS, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2020-07-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 79790-000 |
NDC Item 82776000015
| NDC 9 | 82776-000 |
|---|---|
| NDC 10 | 82776-000-15 |
| NDC Item | 82776000015 |
| Packaging | 1 BOTTLE in 1 BOX (82776-000-15) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 753734 |
| Labeler | THE WOUND DOCS, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2022-06-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 82776-000 |
NDC Item 43074010301
| NDC 9 | 43074-103 |
|---|---|
| NDC 10 | 43074-103-01 |
| NDC Item | 43074010301 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 30125 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2010-08-24 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-103 |
NDC Item 43074010801
| NDC 9 | 43074-108 |
|---|---|
| NDC 10 | 43074-108-01 |
| NDC Item | 43074010801 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 30283 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2010-08-24 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-108 |
NDC Item 43074011501
| NDC 9 | 43074-115 |
|---|---|
| NDC 10 | 43074-115-01 |
| NDC Item | 43074011501 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 38806 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2011-02-15 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-115 |
NDC Item 43074011601
| NDC 9 | 43074-116 |
|---|---|
| NDC 10 | 43074-116-01 |
| NDC Item | 43074011601 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 38788 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2011-02-15 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-116 |
NDC Item 69006001100
| NDC 9 | 69006-011 |
|---|---|
| NDC 10 | 69006-011-00 |
| NDC Item | 69006001100 |
| Packaging | 1 BOTTLE in 1 BOX (69006-011-00) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 750209 |
| Labeler | Viaderma II, Inc |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2020-05-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 69006-011 |
NDC Item 71262000200
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-00 |
| NDC Item | 71262000200 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-00) / 5 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000201
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-01 |
| NDC Item | 71262000201 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-01) / 60 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000202
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-02 |
| NDC Item | 71262000202 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-02) / 100 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000215
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-15 |
| NDC Item | 71262000215 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-15) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000901
| NDC 9 | 71262-009 |
|---|---|
| NDC 10 | 71262-009-01 |
| NDC Item | 71262000901 |
| Packaging | 1 BOTTLE in 1 CARTON (71262-009-01) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 801037 |
| Labeler | VIADERMA DISTRIBUTION INC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2024-05-01 |
| Marketing status | active |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-009 |
NDC Item 72053000000
| NDC 9 | 72053-000 |
|---|---|
| NDC 10 | 72053-000-00 |
| NDC Item | 72053000000 |
| Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-000-00) / 3 g in 1 BOTTLE, DROPPER |
| FDA SPL set id | 750517 |
| Labeler | Patient Focused Tele-Health, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2018-04-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 72053-000 |
NDC Item 72053000201
| NDC 9 | 72053-002 |
|---|---|
| NDC 10 | 72053-002-01 |
| NDC Item | 72053000201 |
| Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-002-01) / 3 g in 1 BOTTLE, DROPPER |
| FDA SPL set id | 750595 |
| Labeler | Patient Focused Tele-Health, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2020-09-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 72053-002 |
NDC Item 79790000000
| NDC 9 | 79790-000 |
|---|---|
| NDC 10 | 79790-000-00 |
| NDC Item | 79790000000 |
| Packaging | 1 BOTTLE in 1 BOX (79790-000-00) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 750404 |
| Labeler | WOUNDS PROS, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2020-07-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 79790-000 |
NDC Item 82776000015
| NDC 9 | 82776-000 |
|---|---|
| NDC 10 | 82776-000-15 |
| NDC Item | 82776000015 |
| Packaging | 1 BOTTLE in 1 BOX (82776-000-15) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 753734 |
| Labeler | THE WOUND DOCS, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2022-06-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 82776-000 |
NDC Item 43074010301
| NDC 9 | 43074-103 |
|---|---|
| NDC 10 | 43074-103-01 |
| NDC Item | 43074010301 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 30125 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2010-08-24 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-103 |
NDC Item 43074010801
| NDC 9 | 43074-108 |
|---|---|
| NDC 10 | 43074-108-01 |
| NDC Item | 43074010801 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 30283 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2010-08-24 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-108 |
NDC Item 43074011501
| NDC 9 | 43074-115 |
|---|---|
| NDC 10 | 43074-115-01 |
| NDC Item | 43074011501 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 38806 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2011-02-15 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-115 |
NDC Item 43074011601
| NDC 9 | 43074-116 |
|---|---|
| NDC 10 | 43074-116-01 |
| NDC Item | 43074011601 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 38788 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2011-02-15 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-116 |
NDC Item 69006001100
| NDC 9 | 69006-011 |
|---|---|
| NDC 10 | 69006-011-00 |
| NDC Item | 69006001100 |
| Packaging | 1 BOTTLE in 1 BOX (69006-011-00) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 750209 |
| Labeler | Viaderma II, Inc |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2020-05-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 69006-011 |
NDC Item 71262000200
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-00 |
| NDC Item | 71262000200 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-00) / 5 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000201
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-01 |
| NDC Item | 71262000201 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-01) / 60 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000202
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-02 |
| NDC Item | 71262000202 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-02) / 100 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000215
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-15 |
| NDC Item | 71262000215 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-15) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000901
| NDC 9 | 71262-009 |
|---|---|
| NDC 10 | 71262-009-01 |
| NDC Item | 71262000901 |
| Packaging | 1 BOTTLE in 1 CARTON (71262-009-01) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 801037 |
| Labeler | VIADERMA DISTRIBUTION INC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2024-05-01 |
| Marketing status | active |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-009 |
NDC Item 72053000000
| NDC 9 | 72053-000 |
|---|---|
| NDC 10 | 72053-000-00 |
| NDC Item | 72053000000 |
| Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-000-00) / 3 g in 1 BOTTLE, DROPPER |
| FDA SPL set id | 750517 |
| Labeler | Patient Focused Tele-Health, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2018-04-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 72053-000 |
NDC Item 72053000201
| NDC 9 | 72053-002 |
|---|---|
| NDC 10 | 72053-002-01 |
| NDC Item | 72053000201 |
| Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-002-01) / 3 g in 1 BOTTLE, DROPPER |
| FDA SPL set id | 750595 |
| Labeler | Patient Focused Tele-Health, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2020-09-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 72053-002 |
NDC Item 79790000000
| NDC 9 | 79790-000 |
|---|---|
| NDC 10 | 79790-000-00 |
| NDC Item | 79790000000 |
| Packaging | 1 BOTTLE in 1 BOX (79790-000-00) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 750404 |
| Labeler | WOUNDS PROS, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2020-07-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 79790-000 |
NDC Item 82776000015
| NDC 9 | 82776-000 |
|---|---|
| NDC 10 | 82776-000-15 |
| NDC Item | 82776000015 |
| Packaging | 1 BOTTLE in 1 BOX (82776-000-15) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 753734 |
| Labeler | THE WOUND DOCS, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2022-06-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 82776-000 |
NDC Item 43074010301
| NDC 9 | 43074-103 |
|---|---|
| NDC 10 | 43074-103-01 |
| NDC Item | 43074010301 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 30125 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2010-08-24 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-103 |
NDC Item 43074010801
| NDC 9 | 43074-108 |
|---|---|
| NDC 10 | 43074-108-01 |
| NDC Item | 43074010801 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 30283 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2010-08-24 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-108 |
NDC Item 43074011501
| NDC 9 | 43074-115 |
|---|---|
| NDC 10 | 43074-115-01 |
| NDC Item | 43074011501 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 38806 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2011-02-15 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-115 |
NDC Item 43074011601
| NDC 9 | 43074-116 |
|---|---|
| NDC 10 | 43074-116-01 |
| NDC Item | 43074011601 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 38788 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2011-02-15 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-116 |
NDC Item 69006001100
| NDC 9 | 69006-011 |
|---|---|
| NDC 10 | 69006-011-00 |
| NDC Item | 69006001100 |
| Packaging | 1 BOTTLE in 1 BOX (69006-011-00) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 750209 |
| Labeler | Viaderma II, Inc |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2020-05-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 69006-011 |
NDC Item 71262000200
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-00 |
| NDC Item | 71262000200 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-00) / 5 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000201
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-01 |
| NDC Item | 71262000201 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-01) / 60 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000202
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-02 |
| NDC Item | 71262000202 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-02) / 100 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000215
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-15 |
| NDC Item | 71262000215 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-15) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000901
| NDC 9 | 71262-009 |
|---|---|
| NDC 10 | 71262-009-01 |
| NDC Item | 71262000901 |
| Packaging | 1 BOTTLE in 1 CARTON (71262-009-01) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 801037 |
| Labeler | VIADERMA DISTRIBUTION INC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2024-05-01 |
| Marketing status | active |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-009 |
NDC Item 72053000000
| NDC 9 | 72053-000 |
|---|---|
| NDC 10 | 72053-000-00 |
| NDC Item | 72053000000 |
| Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-000-00) / 3 g in 1 BOTTLE, DROPPER |
| FDA SPL set id | 750517 |
| Labeler | Patient Focused Tele-Health, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2018-04-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 72053-000 |
NDC Item 72053000201
| NDC 9 | 72053-002 |
|---|---|
| NDC 10 | 72053-002-01 |
| NDC Item | 72053000201 |
| Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-002-01) / 3 g in 1 BOTTLE, DROPPER |
| FDA SPL set id | 750595 |
| Labeler | Patient Focused Tele-Health, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2020-09-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 72053-002 |
NDC Item 79790000000
| NDC 9 | 79790-000 |
|---|---|
| NDC 10 | 79790-000-00 |
| NDC Item | 79790000000 |
| Packaging | 1 BOTTLE in 1 BOX (79790-000-00) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 750404 |
| Labeler | WOUNDS PROS, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2020-07-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 79790-000 |
NDC Item 82776000015
| NDC 9 | 82776-000 |
|---|---|
| NDC 10 | 82776-000-15 |
| NDC Item | 82776000015 |
| Packaging | 1 BOTTLE in 1 BOX (82776-000-15) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 753734 |
| Labeler | THE WOUND DOCS, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2022-06-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 82776-000 |
NDC Item 43074010301
| NDC 9 | 43074-103 |
|---|---|
| NDC 10 | 43074-103-01 |
| NDC Item | 43074010301 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 30125 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2010-08-24 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-103 |
NDC Item 43074010801
| NDC 9 | 43074-108 |
|---|---|
| NDC 10 | 43074-108-01 |
| NDC Item | 43074010801 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 30283 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2010-08-24 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-108 |
NDC Item 43074011501
| NDC 9 | 43074-115 |
|---|---|
| NDC 10 | 43074-115-01 |
| NDC Item | 43074011501 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 38806 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2011-02-15 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-115 |
NDC Item 43074011601
| NDC 9 | 43074-116 |
|---|---|
| NDC 10 | 43074-116-01 |
| NDC Item | 43074011601 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 38788 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2011-02-15 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-116 |
NDC Item 69006001100
| NDC 9 | 69006-011 |
|---|---|
| NDC 10 | 69006-011-00 |
| NDC Item | 69006001100 |
| Packaging | 1 BOTTLE in 1 BOX (69006-011-00) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 750209 |
| Labeler | Viaderma II, Inc |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2020-05-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 69006-011 |
NDC Item 71262000200
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-00 |
| NDC Item | 71262000200 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-00) / 5 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000201
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-01 |
| NDC Item | 71262000201 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-01) / 60 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000202
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-02 |
| NDC Item | 71262000202 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-02) / 100 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000215
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-15 |
| NDC Item | 71262000215 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-15) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000901
| NDC 9 | 71262-009 |
|---|---|
| NDC 10 | 71262-009-01 |
| NDC Item | 71262000901 |
| Packaging | 1 BOTTLE in 1 CARTON (71262-009-01) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 801037 |
| Labeler | VIADERMA DISTRIBUTION INC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2024-05-01 |
| Marketing status | active |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-009 |
NDC Item 72053000000
| NDC 9 | 72053-000 |
|---|---|
| NDC 10 | 72053-000-00 |
| NDC Item | 72053000000 |
| Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-000-00) / 3 g in 1 BOTTLE, DROPPER |
| FDA SPL set id | 750517 |
| Labeler | Patient Focused Tele-Health, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2018-04-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 72053-000 |
NDC Item 72053000201
| NDC 9 | 72053-002 |
|---|---|
| NDC 10 | 72053-002-01 |
| NDC Item | 72053000201 |
| Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-002-01) / 3 g in 1 BOTTLE, DROPPER |
| FDA SPL set id | 750595 |
| Labeler | Patient Focused Tele-Health, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2020-09-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 72053-002 |
NDC Item 79790000000
| NDC 9 | 79790-000 |
|---|---|
| NDC 10 | 79790-000-00 |
| NDC Item | 79790000000 |
| Packaging | 1 BOTTLE in 1 BOX (79790-000-00) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 750404 |
| Labeler | WOUNDS PROS, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2020-07-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 79790-000 |
NDC Item 82776000015
| NDC 9 | 82776-000 |
|---|---|
| NDC 10 | 82776-000-15 |
| NDC Item | 82776000015 |
| Packaging | 1 BOTTLE in 1 BOX (82776-000-15) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 753734 |
| Labeler | THE WOUND DOCS, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2022-06-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 82776-000 |
NDC Item 43074010301
| NDC 9 | 43074-103 |
|---|---|
| NDC 10 | 43074-103-01 |
| NDC Item | 43074010301 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 30125 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2010-08-24 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-103 |
NDC Item 43074010801
| NDC 9 | 43074-108 |
|---|---|
| NDC 10 | 43074-108-01 |
| NDC Item | 43074010801 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 30283 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2010-08-24 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-108 |
NDC Item 43074011501
| NDC 9 | 43074-115 |
|---|---|
| NDC 10 | 43074-115-01 |
| NDC Item | 43074011501 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 38806 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2011-02-15 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-115 |
NDC Item 43074011601
| NDC 9 | 43074-116 |
|---|---|
| NDC 10 | 43074-116-01 |
| NDC Item | 43074011601 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 38788 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2011-02-15 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-116 |
NDC Item 69006001100
| NDC 9 | 69006-011 |
|---|---|
| NDC 10 | 69006-011-00 |
| NDC Item | 69006001100 |
| Packaging | 1 BOTTLE in 1 BOX (69006-011-00) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 750209 |
| Labeler | Viaderma II, Inc |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2020-05-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 69006-011 |
NDC Item 71262000200
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-00 |
| NDC Item | 71262000200 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-00) / 5 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000201
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-01 |
| NDC Item | 71262000201 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-01) / 60 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000202
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-02 |
| NDC Item | 71262000202 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-02) / 100 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000215
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-15 |
| NDC Item | 71262000215 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-15) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000901
| NDC 9 | 71262-009 |
|---|---|
| NDC 10 | 71262-009-01 |
| NDC Item | 71262000901 |
| Packaging | 1 BOTTLE in 1 CARTON (71262-009-01) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 801037 |
| Labeler | VIADERMA DISTRIBUTION INC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2024-05-01 |
| Marketing status | active |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-009 |
NDC Item 72053000000
| NDC 9 | 72053-000 |
|---|---|
| NDC 10 | 72053-000-00 |
| NDC Item | 72053000000 |
| Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-000-00) / 3 g in 1 BOTTLE, DROPPER |
| FDA SPL set id | 750517 |
| Labeler | Patient Focused Tele-Health, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2018-04-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 72053-000 |
NDC Item 72053000201
| NDC 9 | 72053-002 |
|---|---|
| NDC 10 | 72053-002-01 |
| NDC Item | 72053000201 |
| Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-002-01) / 3 g in 1 BOTTLE, DROPPER |
| FDA SPL set id | 750595 |
| Labeler | Patient Focused Tele-Health, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2020-09-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 72053-002 |
NDC Item 79790000000
| NDC 9 | 79790-000 |
|---|---|
| NDC 10 | 79790-000-00 |
| NDC Item | 79790000000 |
| Packaging | 1 BOTTLE in 1 BOX (79790-000-00) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 750404 |
| Labeler | WOUNDS PROS, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2020-07-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 79790-000 |
NDC Item 82776000015
| NDC 9 | 82776-000 |
|---|---|
| NDC 10 | 82776-000-15 |
| NDC Item | 82776000015 |
| Packaging | 1 BOTTLE in 1 BOX (82776-000-15) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 753734 |
| Labeler | THE WOUND DOCS, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2022-06-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 82776-000 |
NDC Item 43074010301
| NDC 9 | 43074-103 |
|---|---|
| NDC 10 | 43074-103-01 |
| NDC Item | 43074010301 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 30125 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2010-08-24 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-103 |
NDC Item 43074010801
| NDC 9 | 43074-108 |
|---|---|
| NDC 10 | 43074-108-01 |
| NDC Item | 43074010801 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 30283 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2010-08-24 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-108 |
NDC Item 43074011501
| NDC 9 | 43074-115 |
|---|---|
| NDC 10 | 43074-115-01 |
| NDC Item | 43074011501 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 38806 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2011-02-15 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-115 |
NDC Item 43074011601
| NDC 9 | 43074-116 |
|---|---|
| NDC 10 | 43074-116-01 |
| NDC Item | 43074011601 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 38788 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2011-02-15 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-116 |
NDC Item 69006001100
| NDC 9 | 69006-011 |
|---|---|
| NDC 10 | 69006-011-00 |
| NDC Item | 69006001100 |
| Packaging | 1 BOTTLE in 1 BOX (69006-011-00) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 750209 |
| Labeler | Viaderma II, Inc |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2020-05-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 69006-011 |
NDC Item 71262000200
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-00 |
| NDC Item | 71262000200 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-00) / 5 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000201
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-01 |
| NDC Item | 71262000201 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-01) / 60 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000202
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-02 |
| NDC Item | 71262000202 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-02) / 100 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000215
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-15 |
| NDC Item | 71262000215 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-15) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000901
| NDC 9 | 71262-009 |
|---|---|
| NDC 10 | 71262-009-01 |
| NDC Item | 71262000901 |
| Packaging | 1 BOTTLE in 1 CARTON (71262-009-01) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 801037 |
| Labeler | VIADERMA DISTRIBUTION INC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2024-05-01 |
| Marketing status | active |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-009 |
NDC Item 72053000000
| NDC 9 | 72053-000 |
|---|---|
| NDC 10 | 72053-000-00 |
| NDC Item | 72053000000 |
| Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-000-00) / 3 g in 1 BOTTLE, DROPPER |
| FDA SPL set id | 750517 |
| Labeler | Patient Focused Tele-Health, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2018-04-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 72053-000 |
NDC Item 72053000201
| NDC 9 | 72053-002 |
|---|---|
| NDC 10 | 72053-002-01 |
| NDC Item | 72053000201 |
| Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-002-01) / 3 g in 1 BOTTLE, DROPPER |
| FDA SPL set id | 750595 |
| Labeler | Patient Focused Tele-Health, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2020-09-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 72053-002 |
NDC Item 79790000000
| NDC 9 | 79790-000 |
|---|---|
| NDC 10 | 79790-000-00 |
| NDC Item | 79790000000 |
| Packaging | 1 BOTTLE in 1 BOX (79790-000-00) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 750404 |
| Labeler | WOUNDS PROS, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2020-07-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 79790-000 |
NDC Item 82776000015
| NDC 9 | 82776-000 |
|---|---|
| NDC 10 | 82776-000-15 |
| NDC Item | 82776000015 |
| Packaging | 1 BOTTLE in 1 BOX (82776-000-15) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 753734 |
| Labeler | THE WOUND DOCS, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2022-06-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 82776-000 |
NDC Item 43074010301
| NDC 9 | 43074-103 |
|---|---|
| NDC 10 | 43074-103-01 |
| NDC Item | 43074010301 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 30125 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2010-08-24 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-103 |
NDC Item 43074010801
| NDC 9 | 43074-108 |
|---|---|
| NDC 10 | 43074-108-01 |
| NDC Item | 43074010801 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 30283 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2010-08-24 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-108 |
NDC Item 43074011501
| NDC 9 | 43074-115 |
|---|---|
| NDC 10 | 43074-115-01 |
| NDC Item | 43074011501 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 38806 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2011-02-15 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-115 |
NDC Item 43074011601
| NDC 9 | 43074-116 |
|---|---|
| NDC 10 | 43074-116-01 |
| NDC Item | 43074011601 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 38788 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2011-02-15 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-116 |
NDC Item 69006001100
| NDC 9 | 69006-011 |
|---|---|
| NDC 10 | 69006-011-00 |
| NDC Item | 69006001100 |
| Packaging | 1 BOTTLE in 1 BOX (69006-011-00) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 750209 |
| Labeler | Viaderma II, Inc |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2020-05-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 69006-011 |
NDC Item 71262000200
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-00 |
| NDC Item | 71262000200 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-00) / 5 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000201
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-01 |
| NDC Item | 71262000201 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-01) / 60 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000202
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-02 |
| NDC Item | 71262000202 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-02) / 100 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000215
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-15 |
| NDC Item | 71262000215 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-15) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000901
| NDC 9 | 71262-009 |
|---|---|
| NDC 10 | 71262-009-01 |
| NDC Item | 71262000901 |
| Packaging | 1 BOTTLE in 1 CARTON (71262-009-01) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 801037 |
| Labeler | VIADERMA DISTRIBUTION INC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2024-05-01 |
| Marketing status | active |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-009 |
NDC Item 72053000000
| NDC 9 | 72053-000 |
|---|---|
| NDC 10 | 72053-000-00 |
| NDC Item | 72053000000 |
| Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-000-00) / 3 g in 1 BOTTLE, DROPPER |
| FDA SPL set id | 750517 |
| Labeler | Patient Focused Tele-Health, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2018-04-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 72053-000 |
NDC Item 72053000201
| NDC 9 | 72053-002 |
|---|---|
| NDC 10 | 72053-002-01 |
| NDC Item | 72053000201 |
| Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-002-01) / 3 g in 1 BOTTLE, DROPPER |
| FDA SPL set id | 750595 |
| Labeler | Patient Focused Tele-Health, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2020-09-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 72053-002 |
NDC Item 79790000000
| NDC 9 | 79790-000 |
|---|---|
| NDC 10 | 79790-000-00 |
| NDC Item | 79790000000 |
| Packaging | 1 BOTTLE in 1 BOX (79790-000-00) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 750404 |
| Labeler | WOUNDS PROS, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2020-07-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 79790-000 |
NDC Item 82776000015
| NDC 9 | 82776-000 |
|---|---|
| NDC 10 | 82776-000-15 |
| NDC Item | 82776000015 |
| Packaging | 1 BOTTLE in 1 BOX (82776-000-15) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 753734 |
| Labeler | THE WOUND DOCS, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2022-06-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 82776-000 |
NDC Item 43074010301
| NDC 9 | 43074-103 |
|---|---|
| NDC 10 | 43074-103-01 |
| NDC Item | 43074010301 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 30125 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2010-08-24 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-103 |
NDC Item 43074010801
| NDC 9 | 43074-108 |
|---|---|
| NDC 10 | 43074-108-01 |
| NDC Item | 43074010801 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 30283 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2010-08-24 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-108 |
NDC Item 43074011501
| NDC 9 | 43074-115 |
|---|---|
| NDC 10 | 43074-115-01 |
| NDC Item | 43074011501 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 38806 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2011-02-15 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-115 |
NDC Item 43074011601
| NDC 9 | 43074-116 |
|---|---|
| NDC 10 | 43074-116-01 |
| NDC Item | 43074011601 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 38788 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2011-02-15 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-116 |
NDC Item 69006001100
| NDC 9 | 69006-011 |
|---|---|
| NDC 10 | 69006-011-00 |
| NDC Item | 69006001100 |
| Packaging | 1 BOTTLE in 1 BOX (69006-011-00) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 750209 |
| Labeler | Viaderma II, Inc |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2020-05-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 69006-011 |
NDC Item 71262000200
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-00 |
| NDC Item | 71262000200 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-00) / 5 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000201
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-01 |
| NDC Item | 71262000201 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-01) / 60 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000202
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-02 |
| NDC Item | 71262000202 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-02) / 100 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000215
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-15 |
| NDC Item | 71262000215 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-15) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000901
| NDC 9 | 71262-009 |
|---|---|
| NDC 10 | 71262-009-01 |
| NDC Item | 71262000901 |
| Packaging | 1 BOTTLE in 1 CARTON (71262-009-01) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 801037 |
| Labeler | VIADERMA DISTRIBUTION INC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2024-05-01 |
| Marketing status | active |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-009 |
NDC Item 72053000000
| NDC 9 | 72053-000 |
|---|---|
| NDC 10 | 72053-000-00 |
| NDC Item | 72053000000 |
| Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-000-00) / 3 g in 1 BOTTLE, DROPPER |
| FDA SPL set id | 750517 |
| Labeler | Patient Focused Tele-Health, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2018-04-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 72053-000 |
NDC Item 72053000201
| NDC 9 | 72053-002 |
|---|---|
| NDC 10 | 72053-002-01 |
| NDC Item | 72053000201 |
| Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-002-01) / 3 g in 1 BOTTLE, DROPPER |
| FDA SPL set id | 750595 |
| Labeler | Patient Focused Tele-Health, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2020-09-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 72053-002 |
NDC Item 79790000000
| NDC 9 | 79790-000 |
|---|---|
| NDC 10 | 79790-000-00 |
| NDC Item | 79790000000 |
| Packaging | 1 BOTTLE in 1 BOX (79790-000-00) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 750404 |
| Labeler | WOUNDS PROS, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2020-07-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 79790-000 |
NDC Item 82776000015
| NDC 9 | 82776-000 |
|---|---|
| NDC 10 | 82776-000-15 |
| NDC Item | 82776000015 |
| Packaging | 1 BOTTLE in 1 BOX (82776-000-15) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 753734 |
| Labeler | THE WOUND DOCS, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2022-06-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 82776-000 |
NDC Item 43074010301
| NDC 9 | 43074-103 |
|---|---|
| NDC 10 | 43074-103-01 |
| NDC Item | 43074010301 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 30125 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2010-08-24 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-103 |
NDC Item 43074010801
| NDC 9 | 43074-108 |
|---|---|
| NDC 10 | 43074-108-01 |
| NDC Item | 43074010801 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 30283 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2010-08-24 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-108 |
NDC Item 43074011501
| NDC 9 | 43074-115 |
|---|---|
| NDC 10 | 43074-115-01 |
| NDC Item | 43074011501 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 38806 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2011-02-15 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-115 |
NDC Item 43074011601
| NDC 9 | 43074-116 |
|---|---|
| NDC 10 | 43074-116-01 |
| NDC Item | 43074011601 |
| Packaging | 3 mL in 1 BOTTLE, DROPPER |
| FDA SPL set id | 38788 |
| Labeler | Phillips Company |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH FINAL |
| Marketing effective time low | 2011-02-15 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_FINAL | part333B |
| Related queries | Properties for NDC 9 43074-116 |
NDC Item 69006001100
| NDC 9 | 69006-011 |
|---|---|
| NDC 10 | 69006-011-00 |
| NDC Item | 69006001100 |
| Packaging | 1 BOTTLE in 1 BOX (69006-011-00) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 750209 |
| Labeler | Viaderma II, Inc |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2020-05-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 69006-011 |
NDC Item 71262000200
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-00 |
| NDC Item | 71262000200 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-00) / 5 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000201
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-01 |
| NDC Item | 71262000201 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-01) / 60 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000202
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-02 |
| NDC Item | 71262000202 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-02) / 100 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000215
| NDC 9 | 71262-002 |
|---|---|
| NDC 10 | 71262-002-15 |
| NDC Item | 71262000215 |
| Packaging | 1 BOTTLE in 1 BOX (71262-002-15) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 750578 |
| Labeler | ViaDerma Distribution, Inc. |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2016-11-08 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-002 |
NDC Item 71262000901
| NDC 9 | 71262-009 |
|---|---|
| NDC 10 | 71262-009-01 |
| NDC Item | 71262000901 |
| Packaging | 1 BOTTLE in 1 CARTON (71262-009-01) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 801037 |
| Labeler | VIADERMA DISTRIBUTION INC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2024-05-01 |
| Marketing status | active |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 71262-009 |
NDC Item 72053000000
| NDC 9 | 72053-000 |
|---|---|
| NDC 10 | 72053-000-00 |
| NDC Item | 72053000000 |
| Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-000-00) / 3 g in 1 BOTTLE, DROPPER |
| FDA SPL set id | 750517 |
| Labeler | Patient Focused Tele-Health, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2018-04-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 72053-000 |
NDC Item 72053000201
| NDC 9 | 72053-002 |
|---|---|
| NDC 10 | 72053-002-01 |
| NDC Item | 72053000201 |
| Packaging | 1 BOTTLE, DROPPER in 1 BOX (72053-002-01) / 3 g in 1 BOTTLE, DROPPER |
| FDA SPL set id | 750595 |
| Labeler | Patient Focused Tele-Health, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2020-09-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 72053-002 |
NDC Item 79790000000
| NDC 9 | 79790-000 |
|---|---|
| NDC 10 | 79790-000-00 |
| NDC Item | 79790000000 |
| Packaging | 1 BOTTLE in 1 BOX (79790-000-00) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 750404 |
| Labeler | WOUNDS PROS, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2020-07-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 79790-000 |
NDC Item 82776000015
| NDC 9 | 82776-000 |
|---|---|
| NDC 10 | 82776-000-15 |
| NDC Item | 82776000015 |
| Packaging | 1 BOTTLE in 1 BOX (82776-000-15) / 15 mL in 1 BOTTLE |
| FDA SPL set id | 753734 |
| Labeler | THE WOUND DOCS, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2022-06-01 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M004 |
| Related queries | Properties for NDC 9 82776-000 |